Haemolytic uraemic syndrome associated with bleomycin, epirubicin and cisplatin chemotherapy: A case report and review of the literature

Acta Oncologica

Volumn 37, Issue 1, 1998, Pages 107-109

  Van Der Heijden, Manon ^b   Ackland, Stephen P ^a   Deveridge, Sandra ^a  

^a NEWCASTLE MATER HOSPITAL   (Australia)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; EPIRUBICIN; MITOMYCIN C;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; DISEASE ASSOCIATION; FEMALE; HEMOPTYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROANGIOPATHY; NASOPHARYNX CARCINOMA; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; UREMIA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CISPLATIN; EPIRUBICIN; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS;

EID: 0031890440     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418698423267     Document Type: Article

References (16)

1. Cvitkovic E, Bachouchi M, Armand J-P, et al. Nasopharyngeal carcinoma: biology, natural history, and therapeutic implications. Hematology Oncology Clinics of North America 1991; 5: 821-38.
2. Bachouchi M, Cvitkovic E, Nasser A, et al. High complete response in advanced nasopharyngeal carcinoma with bleomycin. epirubicin, and cisplatin before radiotherapy. J Natl Cancer Inst 1990; 82: 616-20.
3. Chabner BA, Collins JM. eds. Chapter 13: Bleomycin in cancer chemotherapy: principles & practice. Philadelphia: JB Lippincott, 1990; 341-55.
4. Murgo AJ. Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents. Seminars in Hematology 1987; 24: 161-77.
5. Foerster J. Red cell fragmentation syndromes. In: Lee GR. Bithell TC, Foerster J. et al., eds. Wintrobe's clinical hematology, 9th edn. Philadelphia: Lea & Febiger. 1993: 1215-21.
6. Lesesne JB, Rothschild N, Erickson B, et al. Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry. J Clin Oncol 1989; 7: 781 -9.
7. Gardner G, Mesler D, Gitelman HJ. Hemolytic uremic syndrome following cisplatin, bleomycin. and vincristine chemotherapy: a report of a case and a review of the literature. Renal Failure 1989; 11: 133-7.
8. Torra R, Poch E, Torras A, et al. Pulmonary hemorrhage as a clinical manifestation of hemolytic-uremic syndrome associated with mitomycin C therapy. Chemotherapy 1993: 39: 453-6.
9. Ito K. Komatsu V. Drug induced hemolytic uremic syndrome. Nippon-Rinsho 1993: 51: 204-9.
10. Levi JA, Aroney RS. Dalley DN. Haemolytic anaemia after cisplatin treatment. Br Med J 1981; 282: 2003-4.
11. Jackson AM, Rose BD, Graff LG, et al. Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy. Ann Int Med 1984; 101: 41-4.
12. Licciardello JTW. Moake JL, Rudy CK. et al. Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy. Oncology 1985: 42: 296-300.
13. van der Meer J, de Vries EGE, Vriesendorp R, et al. Hemolytic uremic syndrome in a patient on cis-platinum. vinblastine and bleomycin. J Cancer Res Clin Oncol 1985: 110: 119-22.
14. Desablens B, Fiever P, Pruna A, et al. Hemolytic-uremic syndrome after cancer chemotherapy without mitomycin C. Nephron 1986; 42: 343-4.
15. Doll DC, Cist AJ, Greco A, et al. Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testis. Ann Int Med 1986; 105: 48-51.
16. Vogelzang NJ, Bosl GJ, Johnson K, Kennedy BJ. Raynaud's phenomenon: a common toxicity after combination chemotherapy for testicular cancer. Ann Int Med 1981; 95: 288-92.